Greenfield Savings Bank’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
SAM
FWIA
Greenfield Savings Bank's BMY Position: Q2 2026 in Review
Greenfield Savings Bank reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, selling an estimated $33.2K and leaving 32,823 shares worth $1.89M. The position accounts for 0.72% of the portfolio, ranked #43.
Greenfield Savings Bank first reported a position in BMY in Q2 2022 and has held it in 17 quarters since. The position peaked at $2.03M in Q1 2026. 1,290 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Greenfield Savings Bank held 32,823 shares of Bristol-Myers Squibb worth $1.89M as of Q2 2026.
- Greenfield Savings Bank sold 579 Bristol-Myers Squibb shares in Q2 2026, an estimated $33.2K.
- Bristol-Myers Squibb made up 0.72% of Greenfield Savings Bank's portfolio in Q2 2026, its #43 holding.
- Greenfield Savings Bank first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 17 quarters since.
- Greenfield Savings Bank's Bristol-Myers Squibb position peaked at $2.03M in Q1 2026.
- 1,290 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Greenfield Savings Bank's 13F filing for Q2 2026, filed 7 Jul 2026.